Back to today’s briefing

Story perspectives

Canada Poised to Approve Game-Changing HIV Prevention Drug

6/27/2025

41 3

Summary

Story summary

Canada is on the brink of approving lenacapavir, a groundbreaking injectable HIV prevention drug that only requires two doses a year. With a decision from Health Canada anticipated by mid-2026, advocates stress the urgency for affordable access to ensure at-risk communities aren't left behind due to high costs.

1 of 1

Story summary

Canada is on the brink of approving lenacapavir, a groundbreaking injectable HIV prevention drug that only requires two doses a year. With a decision from Health Canada anticipated by mid-2026, advocates stress the urgency for affordable access to ensure at-risk communities aren't left behind due to high costs.